Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|August 1, 1999
Supplements and Featured Publications
- Vascular Compliance: Clinical and Managed Care Issues
- Volume 5
- Issue 12 Suppl
Can Arterial Stiffness be Reversed? And If So, What are the Benefits?
Author(s)Michel E. Safar, MD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Perindopril: Clinical Profile of a Unique ACE Inhibitorabout 27 years ago
Issues in Vascular Complianceabout 27 years ago
Selected Abstractsabout 27 years ago
BibliographyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5